Regulations/Legal

Latest Issue of OR Manager
February 2025
Home Regulations/Legal

FDA: Five companies are having amoxicillin shortages

Editor's Note As of November 1, the Food and Drug Administration (FDA) listed 26 amoxicillin products on its current drug shortages site. The FDA says increased demand is the largest cause of the shortage. The FDA does not list resupply dates, but the American Society of Health-System Pharmacists (ASHP) estimates…

Read More

By: Judy Mathias
November 1, 2022
Share

CMS penalizes 2,273 hospitals for high readmission rates, lowest since 2014

Editor's Note  The Centers for Medicare & Medicaid Services (CMS), through the Hospital Readmissions Reduction Program, evaluated more than 2 years of readmission cases for Medicare patients and penalized 2,273 hospitals, Kaiser Health News November 1 reports. This is the lowest number of penalties since 2014. The Hospital Readmissions Reduction…

Read More

By: Bridget Brown
November 1, 2022
Share

The Joint Commission announces Health Care Equity Resource Center

Editor's Note The Joint Commission on October 26 announced that it has created a Health Care Equity Resource Center to help organizations monitor their progress toward healthcare equity. New healthcare equity accreditation requirements, which will go into effect January 2023, recognize that organizations need established leaders as well as standardized…

Read More

By: Judy Mathias
October 27, 2022
Share

The Joint Commission will resume certain intracycle calls

Editor's Note The Joint Commission announced on October 26 that it will resume intracycle calls for Disease-Specific Care (DSC) and Health Care Staffing Services (HCSS) certification programs, starting January 1, 2023. These calls, which were suspended in 2021 because of COVID-19, require programs to update their intracycle tabs in the…

Read More

By: Judy Mathias
October 27, 2022
Share

Sponsored Message

FDA: Class I recall of Jiangsu Well Biotech COVID-19 Ag Rapid Test

Editor's Note The Food and Drug Administration (FDA) on October 12 identified the recall of Jiangsu Well Biotech’s COVID-19 Ag Rapid Test Devices as Class I, the most serious. The recall was initiated because the tests were distributed to US customers without authorization, clearance, or approval from the FDA. No…

Read More

By: Judy Mathias
October 26, 2022
Share

COVID-19 vaccine hesitancy among HCWs in academic hospitals

Editor's Note This study led by researchers from Children’s Hospital of Philadelphia examines COVID-19 vaccine hesitancy among healthcare workers (HCWs) at two large academic hospitals in Philadelphia. A total of 5,929 HCWs were surveyed, including 2,253 MDs and DOs, 582 nurse practitioners (NPs), 158 physician assistants (PAs),  and 2,936 nurses.…

Read More

By: Judy Mathias
October 24, 2022
Share

Sponsored Message

The Joint Commission, ACOG announce Advanced Certification in Perinatal Care

Editor's Note The Joint Commission, in collaboration with the American College of Obstetricians and Gynecologists (ACOG), announced on October 20 the launch of Advanced Certification in Perinatal Care (ACPC). ACPC incorporates the latest research, evidence-based practices, and guidance to help improve quality and safety for pregnant or postpartum patients and…

Read More

By: Judy Mathias
October 24, 2022
Share

FDA: Philips Respironics recalls certain BiPAP, CPAP masks

Editor's Note The Food and Drug Administration (FDA) on October 19 identified the recall by Philips Respironics of certain masks for BiPAP and CPAP machines as Class I, the most serious. The recall was initiated because magnetic headgear clips that hold the masks in place can cause injury or death…

Read More

By: Judy Mathias
October 24, 2022
Share

White House releases strategy to improve preparedness for future biological threats

Editor's Note On October 18, the White House released the “National Biodefense Strategy and Implementation Plan for Countering Biological Threats, Enhancing Pandemic Preparedness, and Achieving Global Health Security” (the strategy), Becker's Hospital Review October 19 reports. The strategy includes the objective to create enough vaccines for the US population within…

Read More

By: Bridget Brown
October 21, 2022
Share

Session: Proper Tactics to Prepare for a DEA Inspection

Editor's Note “Is your OR ready for a DEA [Drug Enforcement Administration] inspection?” was the question Dennis Wichern, MBA, partner at Prescription Drug Consulting, asked attendees of this breakout session. As a retired DEA agent, Wichern discussed the ways the DEA has been involved in the medical field, specifically pertaining…

Read More

By: Bridget Brown
October 19, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat